Targeted Molecular Therapeutic Options for Hepatocellular Carcinoma.

Sridhar, Swathi; Sharma, Ishna; Sankpal, Umesh T; Ghabach, Bassam; Narra, Kalyani; Neerukonda, Latha; Basha, Riyaz

Sridhar, Swathi; Sharma, Ishna; Sankpal, Umesh T; Ghabach, Bassam; Narra, Kalyani; Neerukonda, Latha; Basha, Riyaz.

Affiliation

Sridhar S; Texas College of Osteopathic Medicine, University of North Texas Health Science Center at Fort Worth, Fort Worth, Texas.
Sharma I; Texas College of Osteopathic Medicine, University of North Texas Health Science Center at Fort Worth, Fort Worth, Texas.
Sankpal UT; Texas College of Osteopathic Medicine, University of North Texas Health Science Center, Fort Worth, Texas 76107.
Ghabach B; JPS Oncology & Infusion Center, Fort Worth, Texas.
Narra K; JPS Oncology & Infusion Center, Fort Worth, Texas.
Neerukonda L; JPS Oncology and Infusion Center, Fort Worth, Texas.
Basha R; Graduate School of Biomedical Sciences, The University of North Texas Health Science Center, Fort Worth, Texas; Department of Pediatrics and Women's Health, Texas College of Osteopathic Medicine, The University of North Texas Health Science Center, Fort Worth, Texas.

Crit Rev Oncog ; 25(1): 47-55, 2020.

Article de En | MEDLINE | ID: mdl-32865910

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome hépatocellulaire / Thérapie moléculaire ciblée / Tumeurs du foie Type d'étude: Risk_factors_studies Limites: Humans Langue: En Journal: Crit Rev Oncog Sujet du journal: NEOPLASIAS Année: 2020 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google